Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Oct 26, 2011


Bernhard Sixt has resigned as CEO of Agendia, the company said this week.

Sixt, a co-founder of the company who served at its helm since 2003, will remain with Agendia in an "advisory capacity."

Agendia has tapped David Macdonald to replace Sixt as CEO. He previously served as the company's chief operating officer. Prior to that, he worked at Quest Diagnostics, Behring Diagnostics, and Novo Medical.

Macdonald holds a BS in management and finance from Northeastern University and an MBA from Babson College.

Agendia also said that Colin Goddard has joined its supervisory board of directors. Goddard is CEO of Coferon.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.